Key Takeaways
- • L Catterton is divesting supplements provider Thorne to Procter & Gamble for $3.8 billion, marking a significant exit from the health and wellness sector for the luxury-focused investment firm.
- • Drake Gordon, Thorne's founder, will retain a substantial ownership stake and continue in his roles as chairman and CEO, signaling continuity in the company's leadership and strategic direction post-acquisition.
- • The transaction values Thorne at $3.8 billion, reflecting P&G's strategic interest in expanding its portfolio within the high-growth dietary supplements and wellness market.
- • This deal represents L Catterton's exit strategy from a consumer health investment, potentially unlocking capital for deployment in other alternative investment opportunities within its investment mandate.
Summary
L Catterton has agreed to sell Thorne, a supplements and wellness products provider, to Procter & Gamble for $3.8 billion. The transaction demonstrates P&G's continued expansion into the nutritional supplements and health-focused consumer goods sectors, areas that have experienced sustained demand growth among consumers prioritizing preventative health and wellness.
Under the terms of the deal, Drake Gordon, Thorne's founder, will maintain a meaningful ownership position and retain his positions as chairman and CEO. This retention of founder ownership and operational control is a common structure in large acquisitions, particularly when the selling investor seeks to ensure business continuity and leverage the original founder's brand credibility and strategic vision.
L Catterton, the investment firm affiliated with luxury conglomerate LVMH, has positioned itself across consumer health, beauty, and lifestyle sectors. The divestiture of Thorne represents a capital redeployment opportunity for the firm and marks a liquidity event that allows L Catterton to realize returns on its investment in the supplements provider. The $3.8 billion valuation underscores the market's valuation of premium wellness brands in the current environment.
For P&G, the acquisition extends its presence in the supplements space, complementing its existing consumer health portfolio. The deal reflects broader industry trends of large consumer packaged goods companies acquiring specialized wellness and nutritional supplement brands to capture growth in adjacent health-focused categories.
Under the terms of the deal, Drake Gordon, Thorne's founder, will maintain a meaningful ownership position and retain his positions as chairman and CEO. This retention of founder ownership and operational control is a common structure in large acquisitions, particularly when the selling investor seeks to ensure business continuity and leverage the original founder's brand credibility and strategic vision.
L Catterton, the investment firm affiliated with luxury conglomerate LVMH, has positioned itself across consumer health, beauty, and lifestyle sectors. The divestiture of Thorne represents a capital redeployment opportunity for the firm and marks a liquidity event that allows L Catterton to realize returns on its investment in the supplements provider. The $3.8 billion valuation underscores the market's valuation of premium wellness brands in the current environment.
For P&G, the acquisition extends its presence in the supplements space, complementing its existing consumer health portfolio. The deal reflects broader industry trends of large consumer packaged goods companies acquiring specialized wellness and nutritional supplement brands to capture growth in adjacent health-focused categories.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.